Adial Pharmaceuticals (ADIL) Total Non-Current Liabilities (2022 - 2024)
Adial Pharmaceuticals' Total Non-Current Liabilities history spans 2 years, with the latest figure at $929156.0 for Q3 2024.
- For Q3 2024, Total Non-Current Liabilities rose 78.14% year-over-year to $929156.0; the TTM value through Sep 2024 reached $929156.0, up 78.14%, while the annual FY2023 figure was $563785.0, N/A changed from the prior year.
- Total Non-Current Liabilities for Q3 2024 was $929156.0 at Adial Pharmaceuticals, up from $454905.0 in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $929156.0 in Q3 2024 and bottomed at $302286.0 in Q1 2024.